Di Kang
3PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|May 07, 2025
JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies.Di Kang, Yanping Wang, Yiwei Lin
|Apr 30, 2025
Glecirasib, a Potent and Selective Covalent KRAS G12C Inhibitor Exhibiting Synergism with Cetuximab or SHP2 Inhibitor JAB-3312.Peng Wang, Xin Sun, Xueting He
|Aug 07, 2024
Discovery of JAB-3312, a Potent SHP2 Allosteric Inhibitor for Cancer Treatment.Cunbo Ma, Di Kang, Panliang Gao
Pageof 1
